Let's talk medical research

When considering joining a clinical trial, many individuals may feel unsure if it is the right choice for them. There are many things to consider when making this decision, and it is a personal one — but making the choice to participate in medical studies can be rewarding in many ways.

Also known as endometrial carcinoma or uterine cancer, endometrial cancer occurs when the cells that line the uterus begin growing uncontrollably. Though the mortality rates are relatively low due to the high rate of early detection, it is a cancer that impacts nearly 70,000 people every year.

Recruiting and retaining patients are two of the most challenging aspects of clinical trials. The average clinical trial must extend its recruitment timeline by 71%, and up to 30% of patients will eventually drop out. While patients can leave a trial if it is not a good fit for them, there are patient-centric approaches that can make enrolling and participating in a study a more enjoyable ...

This Sunday, June 2, is National Cancer Survivors Day, designed to be a celebration for those who have survived cancer and an inspiration for those recently diagnosed. Since 1991, the national cancer death rate has dropped by 33%, partially due to advancements in treatment, early detection, and reduced smoking rates.

One may choose to participate in a clinical trial for many reasons. Volunteering often has multiple benefits, from advancing medical research to gaining access to cutting-edge medical care. However, deciding to enroll in a clinical trial is only one part of the process.

Colorectal cancer, often shortened just to colon cancer, is the third most commonly diagnosed cancer in the United States aside from skin cancers. While there are treatments available, including radiation and chemotherapy, the most important aspect of successful treatment is early detection — which is why knowing the colon cancer screening guidelines is essential.

Diversity is an essential aspect of medical research for many reasons. Ensuring equitable access to healthcare is vital, as it is a critical component of understanding the efficacy of potential new treatments and can improve the overall health of all individuals.

For medications to work effectively for all who need them, clinical trials need to include a diverse cross-section of the population. However, although nearly 40% of the United States population is racial and ethnic minorities, estimated rates of research participation for these groups range from just 2% to 16%.

Artificial intelligence, most commonly known as AI, has become a buzzword across many industries. While it is most commonly used in relation to art generators or web searches, AI has many practical applications beyond these uses — especially within the clinical trial marketing space. The global market size of AI-based clinical trial marketing is expected to reach nearly 8 billion by 2031, mainly ...

We are thrilled to be honored as the Multiple Sclerosis Association of America’s Corporate Honoree at their 10th annual Improving Lives Benefit on May 15! This inspiring event supports MSAA’s free programs and services and honors key players in the MS research space.